Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update

Go back to Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update
(NYSE: RCUS) Delayed: 28.18 +0.95 (3.49%)
Previous Close $27.23    52 Week High
Open $26.72    52 Week Low
Day High $28.27    P/E N/A 
Day Low $26.72    EPS
Volume 2,341,907